Whole-body metabolic modelling predicts isoleucine dependency of SARS-CoV-2 replication
- PMID: 35874091
- PMCID: PMC9296228
- DOI: 10.1016/j.csbj.2022.07.019
Whole-body metabolic modelling predicts isoleucine dependency of SARS-CoV-2 replication
Abstract
We aimed at investigating host-virus co-metabolism during SARS-CoV-2 infection. Therefore, we extended comprehensive sex-specific, whole-body organ resolved models of human metabolism with the necessary reactions to replicate SARS-CoV-2 in the lung as well as selected peripheral organs. Using this comprehensive host-virus model, we obtained the following key results: 1. The predicted maximal possible virus shedding rate was limited by isoleucine availability. 2. The supported initial viral load depended on the increase in CD4+ T-cells, consistent with the literature. 3. During viral infection, the whole-body metabolism changed including the blood metabolome, which agreed well with metabolomic studies from COVID-19 patients and healthy controls. 4. The virus shedding rate could be reduced by either inhibition of the guanylate kinase 1 or availability of amino acids, e.g., in the diet. 5. The virus variants differed in their maximal possible virus shedding rates, which could be inversely linked to isoleucine occurrences in the sequences. Taken together, this study presents the metabolic crosstalk between host and virus and emphasises the role of amino acid metabolism during SARS-CoV-2 infection, in particular of isoleucine. As such, it provides an example of how computational modelling can complement more canonical approaches to gain insight into host-virus crosstalk and to identify potential therapeutic strategies.
Keywords: Constraint-based modelling; Covid-19; Isoleucine; Metabolic modelling; SARS-CoV-2 infection; Variants of concerns.
© 2022 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests that could have appeared to influence the work reported in this paper.
Figures
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9379497/bin/ga1.gif)
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9379497/bin/gr1.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9379497/bin/gr2.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9379497/bin/gr3.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9379497/bin/gr4.gif)
![Fig. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9379497/bin/gr5.gif)
Similar articles
-
Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG) in SARS-CoV-2 infection: Major interactions with host/virus proteases.Phytomed Plus. 2023 Feb;3(1):100402. doi: 10.1016/j.phyplu.2022.100402. Epub 2022 Dec 30. Phytomed Plus. 2023. PMID: 36597465 Free PMC article. Review.
-
Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction.Elife. 2022 Nov 23;11:e80329. doi: 10.7554/eLife.80329. Elife. 2022. PMID: 36416537 Free PMC article.
-
Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study.Lancet Respir Med. 2022 Nov;10(11):1061-1073. doi: 10.1016/S2213-2600(22)00226-0. Epub 2022 Aug 18. Lancet Respir Med. 2022. PMID: 35988572 Free PMC article.
-
[Shedding of SARS-CoV-2 Virus in COVID-19 Patients and Neutralizing Antibody Level].Mikrobiyol Bul. 2022 Jul;56(3):416-431. doi: 10.5578/mb.20229704. Mikrobiyol Bul. 2022. PMID: 35960235 Turkish.
-
Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19.J Med Virol. 2022 Apr;94(4):1300-1314. doi: 10.1002/jmv.27467. Epub 2021 Nov 29. J Med Virol. 2022. PMID: 34811761 Free PMC article. Review.
Cited by
-
Whole-body metabolic modelling reveals microbiome and genomic interactions on reduced urine formate levels in Alzheimer's disease.Sci Rep. 2024 Mar 13;14(1):6095. doi: 10.1038/s41598-024-55960-3. Sci Rep. 2024. PMID: 38480804 Free PMC article.
-
Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart.BMC Bioinformatics. 2023 Sep 27;24(1):364. doi: 10.1186/s12859-023-05487-7. BMC Bioinformatics. 2023. PMID: 37759157 Free PMC article.
-
The Effects of Hospitalisation on the Serum Metabolome in COVID-19 Patients.Metabolites. 2023 Aug 16;13(8):951. doi: 10.3390/metabo13080951. Metabolites. 2023. PMID: 37623894 Free PMC article.
-
Integrated NMR and MS Analysis of the Plasma Metabolome Reveals Major Changes in One-Carbon, Lipid, and Amino Acid Metabolism in Severe and Fatal Cases of COVID-19.Metabolites. 2023 Jul 24;13(7):879. doi: 10.3390/metabo13070879. Metabolites. 2023. PMID: 37512587 Free PMC article.
-
Context-Specific Genome-Scale Metabolic Modelling and Its Application to the Analysis of COVID-19 Metabolic Signatures.Metabolites. 2023 Jan 13;13(1):126. doi: 10.3390/metabo13010126. Metabolites. 2023. PMID: 36677051 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous